As Angela Lukin, US president of global primary care at Pfizer, said: “Based on our current understanding, when we enter a traditional commercial model, anyone with commercial or government ...

Pfizer will pay $60 million to settle allegations that one of its subsidiaries incentivized healthcare providers to prescribe ...

Pfizer’s CEO stated that the company revamped its commercial strategy, brought in new leadership, and exceeded market share expectations. On the cost side, Pfizer achieved $4 billion in savings ...

Fonseca joined Pfizer in 2019, bringing more than 20 years ... need to work together to provide that experience. “In the commercial and medical space, digital medicines and digital health ...

David Werner Real Estate Investments and Metro Loft Management will redevelop two buildings into more than 1,600 units.

Citi analyst Geoff Meacham lowered the firm’s price target on Pfizer (PFE) to $29 from $30 and keeps a Neutral rating on the shares. Ahead of ...

Financial analysis of Pfizer Inc. stock ahead of its earnings release. PFE faces significant headwinds from patent expiries, click for my updated look at the stock.